Drugs / Corynebacterium granulosum P40
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00002455 | Apr 1971 → ? | breast cancer, colorectal cancer, cutaneous melanoma | Centro Oncologico de Excelencia | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Corynebacterium granulosum P40 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00002455 ↗ |
| Route | Subcutaneous | “patients receive Corynebacterium granulosum P40 subcutaneously weekly for 6 weeks” NCT00002455 ↗ |